Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study.

ABSTRACT:

Introduction

Dementia is a leading and growing cause of morbidity and mortality. The aim of this study was to investigate real-world prescription patterns of antidementive medication in one of the largest cohorts published thus far to optimize use in this growing population.

Methods

Prescription claims from 2005 to 2016 were provided by Austrian sickness funds, covering 98% of the population of Austria. Patients treated with at least one of the four approved antidementive drugs (ADDs) were included. Prescription prevalence was calculated for 2014 and 2015, and prescription patterns were traced on an individual level during the entire study period.

Results

A total of 127,896 patients were treated with an ADD between 2005 and 2016. The prevalence was 0.93% in 2014 and 1

SUBMITTER: Wurm R 

PROVIDER: S-EPMC7189407 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature